Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

All 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...

The findings show that the increased ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study found that a tiny ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...